As of 2025-12-17, the Relative Valuation of Cara Therapeutics Inc (CARA) is (233.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -4486.8%.
The range of the Relative Valuation is (167.17) - (251.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 16.2x | 13.8x |
| Forward P/E multiples | 10.8x - 18.7x | 16.3x |
| Fair Price | (167.17) - (251.21) | (233.38) |
| Upside | -3242.2% - -4822.1% | -4486.8% |
| Date | P/E |